DigitalHealth.London Accelerator
VC Fund
London, United Kingdom
DigitalHealth.London Accelerator is a VC fund in London focused on Health Care and Medical. DigitalHealth.London Accelerator programme is uniquely positioned to provide in-depth knowledge of the NHS to a cohort of high potential small and medium sized businesses (SMEs). The Accelerator aims to speed up the adoption of innovation at scale, ensuring that greater numbers of patients benefit from emerging new technology, more rapidly.It’sthe first programme of its kind, based in London, which draws upon a number of key founding and strategic partners, who together bring a rich and diverse collateral of resources and expertise across healthcare, research, innovation, digital health and tech.
- Total investments:
- 128
- Last investment:
- Lead investor:
- 68%
Last updated:
For AI agents: llms.txt
Industries DigitalHealth.London Accelerator invests in
Stages DigitalHealth.London Accelerator invests in
Countries DigitalHealth.London Accelerator invests in
Investment Focus
Industry
- Health Care 102 (80%)
- Medical 34 (27%)
- Software 29 (23%)
- Wellness 24 (19%)
- Information Technology 21 (16%)
Stage
- Non-equity Assistance 72 (56%)
- Seed 34 (27%)
- Funding Round 17 (13%)
- Pre-Seed 5 (4%)
Country
- United Kingdom 104 (81%)
- United States 8 (6%)
- Ireland 3 (2%)
- Belgium 2 (2%)
- India 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
DynaTechAnalytics
|
Artificial intelligence driven software applications for digital health technologies. We train multimodal systems to be able to execute automated administration optimisation tasks as well as repetitive patient monitoring and classification solutions. We work closely with the NHS. | $52.5K / Pre-Seed / Jan 04, 2024 | |
Hippo Labs
|
We're a small London based tech startup that helps GP practices to operate more efficiently and effectively. We're starting with a focus on proactive care to help improve outcomes for patients and reduce workload for practices. | Non-equity Assistance / Jul 03, 2023 | |
Blinx Solutions, Ltd.
|
Blinx is a new type of Business Intelligence app focused on Supply Chain & Finance process optimisation. | Non-equity Assistance / Jul 03, 2023 | |
Mobilise
|
Providing support for unpaid carers | Non-equity Assistance / Jul 03, 2023 | |
PMD Solutions
|
PMD Solutions is aiming to revolutionise the traditional methods of respiratory monitoring with a discrete, body worn, wireless sensor that comprehensively and continuously monitors patients’ respiratory rate from administration to discharge. | Non-equity Assistance / Jul 03, 2023 | |
Abtrace
|
Abtrace is a provider of digital health solutions that scale medical expertise. It eliminates duplication and improves patient safety while saving GP time and lowering practice costs. | Non-equity Assistance / Jul 03, 2023 | |
Opto Health
|
Opto Health is a healthcare compnay the provides intuitive entry for Urgent and Emergency Care. | Jul 03, 2023 | |
Bingli
|
Bingli is a telemedicine consulting service provider company focuses on dynamic patient history and patient planning. | Non-equity Assistance / Jul 03, 2023 | |
TestCard
|
TestCard is the UK & US based medical technology innovator behind the eponymous at-home medical test kit technology. Founded by Dr Andrew Botham and Luke Heron in 2017; the company has been a leading pioneer in the fast emerging paradigm shift away from curative care towards predictive, preventative and pre-emptive at-home healthcare solutions.The business is ultimately a platform technology with an accompanying flat-pack urine test kit, allowing consumers to diagnose and monitor common conditions and diseases in the privacy, comfort and convenience of home. TestCard's partnering mobile application turns a mobile phone’s camera into a clinical grade scanner, providing the user with an immediate and accurate result from the TestCard, communicated in easily understood results displayed on the phone screen. The company has medical devices approved for at-home use for the detection of urinary tract infections (UTI) in 27 countries and has filings underway for pregnancy, ovulation optimisation and diabetes management (among others). | Jul 03, 2023 | |
Kidney Beam
|
Kidney Beam is an educational and well-being platform developed for people living with chronic kidney disease. | Non-equity Assistance / Jul 03, 2023 | |
| See all 128 investments → | |||
Co-Investors
Finance Yorkshire
3 deals together
SFC Capital
3 deals together
Calm/Storm VC
2 deals together
Deeptech Labs
2 deals together
Google for Startups
2 deals together
NHS Innovation Accelerator
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does DigitalHealth.London Accelerator invest in?
DigitalHealth.London Accelerator invests primarily in Health Care, Medical and Software startups, most often at Non-equity Assistance and Seed stage. Most of the 128 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did DigitalHealth.London Accelerator last invest?
The most recent investment recorded for DigitalHealth.London Accelerator closed in Jan 2024. Shizune tracks 128 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
